Skip to main content
. Author manuscript; available in PMC: 2019 Oct 18.
Published in final edited form as: Cytokine. 2019 Jan 8;115:60–63. doi: 10.1016/j.cyto.2018.12.010

Fig. 3. TGF-β-based immunosuppression in the implant microenvironment.

Fig. 3.

Biomaterial-based delivery of exogenous TGF-β initiates the transcriptional inhibition of inflammatory cytokines, recruitment and proliferation of various resident macrophages and T-cells to attenuate host immune responses and inflammation.